GGastroenterology3/1/2026Efimosfermin, a fibroblast growth factor 21 analogue, for metabolic dysfunction-associated steatohepatitisBenjamin H. MullishRead at GastroenterologyTagsFibroblast Growth Factor ResearchMolecular Biology
